Exagen Inc. Common Stock

XGNNASDAQUSD
3.13 USD
0.07 (2.12%)🟢LIVE (AS OF 02:53 PM EDT)
🟢Market: OPEN
Open?$3.07
High?$3.23
Low?$3.08
Prev. Close?$3.06
Volume?123.7K
Avg. Volume?316.4K
VWAP?$3.16
Rel. Volume?0.39x
Bid / Ask
Bid?$3.12 × 100
Ask?$3.15 × 100
Spread?$0.03
Midpoint?$3.14
Valuation & Ratios
Market Cap?73.6M
Shares Out?24.1M
Float?15.1M
Float %?66.5%
P/E Ratio?N/A
P/B Ratio?4.22
EPS?-$0.83
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?3.45Strong
Quick Ratio?3.45Strong
Cash Ratio?2.28Strong
Debt/Equity?1.49Moderate
ValuationATTRACTIVELY VALUED
Score
92/100
P/E?
N/A
P/B?
4.22FAIR
P/S?
1.11CHEAP
P/FCF?
N/A
EV/EBITDA?
-5.6CHEAP
EV/Sales?
1.01CHEAP
Returns & Efficiency
ROE?
-114.3%WEAK
ROA?
-34.4%WEAK
Cash Flow & Enterprise
FCF?$-14266000
Enterprise Value?$67.4M
Related Companies
Loading...
News
Profile
Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.
Employees
220
Market Cap
73.6M
Industry
SERVICES-MEDICAL LABORATORIES
Listed
2019-09-19
Address
1261 LIBERTY WAY
VISTA, CA 92081
Phone: (760) 560-1501